1h Free Analyst Time
The microbiomes market is forecasted to grow by USD 1,132.78 million during 2023-2028, accelerating at a CAGR of 22.67% during the forecast period. The report on the microbiomes market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of diseases, increasing initiatives and investments in microbiome research, and advances in microbiome discovery, therapeutics, and diagnostics.
The microbiomes market is segmented as below:
By Product
- Probiotics
- Foods
- Prebiotics
- Medical food
- Others
By Application
- Therapeutics
- Diagnostics
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the microbiomes market covers the following areas:
- Microbiomes market sizing
- Microbiomes market forecast
- Microbiomes market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by Application
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The analyst recognizes the following companies as the key players in the global microbiomes market: AOBiome LLC, BiomX Inc., DuPont de Nemours Inc., Eligo Bioscience, ENTEROME SA, Evelo Biosciences Inc., ExeGi Pharma, Ferring BV, MaaT Pharma, OraSure Technologies Inc., Osel Inc., Pendulum Therapeutics Inc., PureTech Health Plc, Qualigen Therapeutics Inc., Second Genome Therapeutics, Seres Therapeutics Inc., Synlogic Inc., Takeda Pharmaceutical Co. Ltd., Vedanta Biosciences Inc., YSOPIA Bioscience, and THERIVA BIOLOGICS INC.Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is significant number of collaborations for developing microbiome therapeutics.'
According to the report, one of the major drivers for this market is the increasing prevalence of diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AOBiome LLC
- BiomX Inc.
- DuPont de Nemours Inc.
- Eligo Bioscience
- ENTEROME SA
- Evelo Biosciences Inc.
- ExeGi Pharma
- Ferring BV
- MaaT Pharma
- OraSure Technologies Inc.
- Osel Inc.
- Pendulum Therapeutics Inc.
- PureTech Health Plc
- Qualigen Therapeutics Inc.
- Second Genome Therapeutics
- Seres Therapeutics Inc.
- Synlogic Inc.
- Takeda Pharmaceutical Co. Ltd.
- Vedanta Biosciences Inc.
- YSOPIA Bioscience
- THERIVA BIOLOGICS INC.
